Abaloparatide and Teriparatide Interaction

Avoid
Researched 95% confidence

Abaloparatide and Teriparatide have a potentially harmful interaction with 95% confidence. Do not use concurrently; both are PTH receptor agonists. Choose one or use sequentially. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

Abaloparatide

PTHrP Analog | Anabolic Bone-Building Agent

Abaloparatide works through selective activation of the parathyroid hormone 1 receptor (PTH1R), a G protein-coupled receptor expressed on osteoblasts and osteocytes. It preferentially binds to the RG (relaxed, G-protein-coupled) conformational state of PTH1R, which elicits a transient downstream cyclic AMP signaling response favoring anabolic bone formation over resorption.

Half-life: ~1.7 hours Typical dose: 80 mcg healing
histamine h1pth receptor teratogenic
View full profile

Teriparatide

PTH(1-34) | Bone-Building Anabolic Peptide

Teriparatide binds to PTH type 1 receptors (G-protein coupled receptors) on osteoblasts, osteocytes, and renal tubular cells. This activates PKA and PKC signaling pathways that promote osteoblast activity.

Half-life: ~1 hour (subcutaneous); ~5 minutes (intravenous) Typical dose: 20mcg daily (FDA-approved dose) healing
igf1pth receptor teratogenic
View full profile

Combined Organ Load

Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Abaloparatide, Teriparatide). Monitor accordingly.

Frequently Asked Questions

Can I take Abaloparatide with Teriparatide?

Combining Abaloparatide with Teriparatide is not recommended. Do not use concurrently; both are PTH receptor agonists. Choose one or use sequentially.

Is Abaloparatide and Teriparatide safe together?

This combination carries significant risk. Do not use concurrently; both are PTH receptor agonists. Choose one or use sequentially. Consult a healthcare professional before combining.

What are the interactions between Abaloparatide and Teriparatide?

Do not use concurrently; both are PTH receptor agonists. Choose one or use sequentially. This assessment has 95% confidence and is based on documented research data.

How should I time Abaloparatide and Teriparatide?

Abaloparatide has a half-life of ~1.7 hours and Teriparatide has a half-life of ~1 hour (subcutaneous); ~5 minutes (intravenous). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Abaloparatide vs Teriparatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.